2014年12月9日至13日于美国得克萨斯州圣安东尼奥市召开的第37届圣安东尼奥乳腺癌研讨会报告。
Report from the 37th san antonio breast cancer symposium, 9-13th december 2014, Texas, USA.
作者信息
Ahmed M, Esposito E
机构信息
Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital Campus, London SE1 9RT, UK.
Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital Campus, London SE1 9RT, UK ; Department of Clinical Medicine and Surgery, Breast Unit, University of Naples Federico II, Naples 80131, Italy.
出版信息
Ecancermedicalscience. 2015 Feb 4;9:508. doi: 10.3332/ecancer.2015.508. eCollection 2015.
The 37th San Antonio Breast Cancer Symposium (SABCS) was held at the Henry B. Gonzalez Conference Centre in San Antonio, Texas, USA between the 9 and 13th of December 2014. It brought together an interaction between basic scientists and clinicians involved in the management of breast cancer. The symposium included six general sessions, poster discussion, and poster sessions. The most important highlights in the fields of advancing endocrine therapy; hormone receptor positive advanced breast cancer and hormonal resistant therapy; targeted therapies; genetics and genomics; supportive (adjunct) care; chemotherapy treatments; breast screening and risk stratification; male breast cancer and future potential directions were included here.
第37届圣安东尼奥乳腺癌研讨会（SABCS）于2014年12月9日至13日在美国得克萨斯州圣安东尼奥的亨利·B·冈萨雷斯会议中心举行。它促成了参与乳腺癌治疗的基础科学家和临床医生之间的互动。该研讨会包括六场全体会议、海报讨论和海报展示环节。这里涵盖了内分泌治疗进展、激素受体阳性晚期乳腺癌和激素抵抗治疗、靶向治疗、遗传学和基因组学、支持性（辅助）护理、化疗治疗方法、乳腺筛查和风险分层、男性乳腺癌以及未来潜在方向等领域的最重要亮点。
Zotero 插件